Literature DB >> 9853796

Auditory laterality and selective attention: normal performance in patients with early-onset schizophrenia.

M Oie1, B R Rund, K Sundet, G Bryhn.   

Abstract

In this study, auditory laterality and selective attention were examined in patients with early-onset schizophrenia using a dichotic listening (DL) test. Deficient performance on this test has repeatedly been found in adult patients with chronic schizophrenia, indicating abnormalities in left hemisphere function. The hypothesis in the present study was that subjects with early-onset schizophrenia manifest deficits in DL test performance similar to adult chronic patients. A group of 19 patients with early-onset schizophrenia were compared with a group of 20 adolescents with attention-deficit hyperactivity disorder and a group of 30 normal adolescents. Results indicated no significant differences between the three groups on any of the measures. Alternative hypotheses are put forth to explain the findings, among them that deficits in DL performance may be secondary to long-time illness and/or drug treatment, and that these deficits may become apparent only after interaction with maturational neurodevelopmental changes during adolescence.

Entities:  

Mesh:

Year:  1998        PMID: 9853796     DOI: 10.1093/oxfordjournals.schbul.a033356

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  2 in total

1.  Neuropsychological functioning in early-onset first-episode psychosis: comparison of diagnostic subgroups.

Authors:  Arantzazu Zabala; Marta Rapado; Celso Arango; Olalla Robles; Elena de la Serna; Cristina González; José Manuel Rodríguez-Sánchez; Patricia Andrés; María Mayoral; Igor Bombín
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-09-19       Impact factor: 5.270

2.  Cognitive functioning in first-episode schizophrenia.

Authors:  Jean Addington; Donald Addington
Journal:  J Psychiatry Neurosci       Date:  2002-05       Impact factor: 6.186

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.